- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/3 | 1.8 | 12.01 | -6.48 | 5.3 | 2.71 | 5.3 | N/A | - | ||
| 2024/2 | 1.61 | -14.94 | 3.06 | 3.5 | 8.19 | 5.14 | N/A | - | ||
| 2024/1 | 1.89 | 15.48 | 12.97 | 1.89 | 12.97 | 5.33 | N/A | - | ||
| 2023/12 | 1.64 | -8.89 | -22.59 | 21.35 | -36.42 | 5.32 | 0.71 | - | ||
| 2023/11 | 1.8 | -4.36 | -14.36 | 19.71 | -37.35 | 5.65 | 0.66 | - | ||
| 2023/10 | 1.88 | -4.62 | -5.11 | 17.91 | -38.99 | 5.7 | 0.66 | - | ||
| 2023/9 | 1.97 | 6.3 | 1.73 | 16.03 | -41.44 | 5.59 | 0.6 | - | ||
| 2023/8 | 1.85 | 4.85 | -14.71 | 14.06 | -44.73 | 5.38 | 0.62 | - | ||
| 2023/7 | 1.77 | 0.46 | -46.31 | 12.21 | -47.53 | 5.33 | 0.62 | - | ||
| 2023/6 | 1.76 | -2.22 | -65.38 | 10.44 | -47.73 | 5.28 | 0.87 | 去年營收因子公司出售快篩試劑，致使本月營收較去年同期減少達50%以上 | ||
| 2023/5 | 1.8 | 4.74 | -65.09 | 8.68 | -41.71 | 5.45 | 0.84 | 去年營收因子公司出售快篩試劑，致使本月營收較去年同期減少達50%以上 | ||
| 2023/4 | 1.72 | -10.82 | -32.9 | 6.88 | -29.33 | 5.21 | 0.88 | - | ||
| 2023/3 | 1.93 | 23.44 | -22.56 | 5.16 | -28.05 | 5.16 | 1.04 | - | ||
| 2023/2 | 1.56 | -6.75 | -29.68 | 3.24 | -30.97 | 5.35 | 1.0 | - | ||
| 2023/1 | 1.67 | -20.87 | -32.13 | 1.67 | -32.13 | 5.89 | 0.91 | - | ||
| 2022/12 | 2.12 | 0.79 | -14.01 | 33.58 | 14.58 | 6.2 | 0.88 | - | ||
| 2022/11 | 2.1 | 5.96 | -19.84 | 31.46 | 17.2 | 6.02 | 0.91 | - | ||
| 2022/10 | 1.98 | 2.25 | -25.28 | 29.36 | 21.21 | 6.09 | 0.9 | - | ||
| 2022/9 | 1.94 | -10.88 | -30.92 | 27.38 | 26.92 | 7.4 | 0.89 | - | ||
| 2022/8 | 2.17 | -33.99 | -17.28 | 25.45 | 35.56 | 10.55 | 0.63 | - | ||
| 2022/7 | 3.29 | -35.22 | 20.12 | 23.27 | 44.17 | 13.53 | 0.49 | - | ||
| 2022/6 | 5.08 | -1.39 | 109.69 | 19.98 | 49.09 | 12.8 | 0.59 | 因嘉碩生醫出售快篩試劑，致使本月營收較去年同期增加達50%以上 | ||
| 2022/5 | 5.16 | 101.32 | 125.9 | 14.89 | 35.7 | 10.21 | 0.74 | 本月營收因子公司出售快篩試劑，致使本月營收較去年同期增加達50%以上 | ||
| 2022/4 | 2.56 | 2.92 | 11.5 | 9.74 | 12.02 | 7.27 | 1.05 | - | ||
| 2022/3 | 2.49 | 12.08 | 4.13 | 7.18 | 12.2 | 7.18 | 0.72 | - | ||
| 2022/2 | 2.22 | -10.0 | 24.43 | 4.69 | 17.02 | 7.15 | 0.72 | - | ||
| 2022/1 | 2.47 | 0.25 | 11.06 | 2.47 | 11.06 | 7.55 | 0.68 | - | ||
| 2021/12 | 2.46 | -6.04 | 23.37 | 29.31 | 37.18 | 7.73 | 0.64 | - | ||
| 2021/11 | 2.62 | -1.22 | 39.04 | 26.84 | 38.6 | 8.07 | 0.61 | - | ||
| 2021/10 | 2.65 | -5.46 | 50.07 | 24.23 | 38.56 | 8.08 | 0.61 | 本月營收因出貨量增加及調整營運策略，致使本月營收較去年同期增加達50%以上 | ||
| 2021/9 | 2.8 | 6.7 | 60.17 | 21.57 | 37.26 | 8.17 | 0.59 | 本月營收因出貨量增加及調整營運策略，致使本月營收較去年同期增加達50%以上 | ||
| 2021/8 | 2.63 | -4.13 | 62.3 | 18.77 | 34.39 | 7.79 | 0.62 | 本月營收因出貨量增加及調整營運策略，致使本月營收較去年同期增加達50%以上 | ||
| 2021/7 | 2.74 | 13.07 | 52.35 | 16.14 | 30.73 | 7.45 | 0.64 | 本月營收因出貨量增加及調整營運策略,致使本月營收較去年同期增加達50%以上。 | ||
| 2021/6 | 2.42 | 6.22 | 41.44 | 13.4 | 27.04 | 7.0 | 0.57 | - | ||
| 2021/5 | 2.28 | -0.63 | 29.17 | 10.98 | 24.24 | 6.97 | 0.57 | - | ||
| 2021/4 | 2.3 | -3.87 | 14.25 | 8.69 | 23.01 | 6.47 | 0.62 | - | ||
| 2021/3 | 2.39 | 33.94 | 24.33 | 6.4 | 26.5 | 6.4 | 0.6 | - | ||
| 2021/2 | 1.78 | -19.67 | 8.94 | 4.01 | 27.82 | 6.0 | 0.64 | - | ||
| 2021/1 | 2.22 | 11.36 | 48.5 | 2.22 | 48.5 | 6.1 | 0.63 | - | ||
| 2020/12 | 1.99 | 5.89 | 9.29 | 21.36 | 5.44 | 5.64 | 0.6 | - | ||
| 2020/11 | 1.88 | 6.61 | -0.38 | 19.37 | 5.06 | 5.4 | 0.63 | - | ||
| 2020/10 | 1.77 | 0.9 | -13.19 | 17.48 | 5.68 | 5.14 | 0.66 | - | ||
| 2020/9 | 1.75 | 8.12 | 7.16 | 15.72 | 8.33 | 5.17 | 0.81 | - | ||
| 2020/8 | 1.62 | -10.01 | -16.72 | 13.97 | 8.48 | 5.13 | 0.82 | - | ||
| 2020/7 | 1.8 | 4.97 | -4.37 | 12.35 | 12.96 | 5.28 | 0.8 | - | ||
| 2020/6 | 1.71 | -2.98 | 0.74 | 10.55 | 16.57 | 5.49 | 0.8 | - | ||
| 2020/5 | 1.77 | -12.1 | 2.51 | 8.83 | 20.23 | 5.7 | 0.77 | - | ||
| 2020/4 | 2.01 | 4.59 | 27.57 | 7.07 | 25.67 | 5.57 | 0.79 | - | ||
| 2020/3 | 1.92 | 17.36 | 29.75 | 5.06 | 24.93 | 5.06 | 0.78 | - | ||
| 2020/2 | 1.64 | 9.49 | 44.01 | 3.13 | 22.14 | 4.96 | 0.79 | - | ||
| 2020/1 | 1.5 | -18.04 | 4.73 | 1.5 | 4.73 | 5.21 | 0.76 | - | ||
| 2019/12 | 1.82 | -3.48 | 41.88 | 20.26 | 9.44 | 5.75 | 0.56 | - | ||
| 2019/11 | 1.89 | -7.09 | 35.38 | 18.43 | 7.02 | 5.56 | 0.58 | - | ||
| 2019/10 | 2.04 | 24.57 | 26.15 | 16.54 | 4.51 | 5.61 | 0.57 | - | ||
| 2019/9 | 1.63 | -15.97 | 5.34 | 14.51 | 2.06 | 5.46 | 0.64 | - | ||
| 2019/8 | 1.94 | 3.32 | 21.26 | 12.87 | 1.66 | 5.53 | 0.63 | - | ||
| 2019/7 | 1.88 | 10.59 | 15.66 | 10.93 | -1.18 | 5.31 | 0.66 | - | ||
| 2019/6 | 1.7 | -1.28 | 16.04 | 9.05 | -4.08 | 5.0 | 0.67 | - | ||
| 2019/5 | 1.72 | 9.38 | 4.65 | 7.35 | -7.79 | 0.0 | N/A | - | ||
| 2019/4 | 1.58 | 6.38 | -9.22 | 5.62 | -11.03 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 1.89 | 2023/1 | 1.67 | 2022/1 | 2.47 | 2021/1 | 2.22 | 2020/1 | 1.5 |
| 2024/2 | 1.61 | 2023/2 | 1.56 | 2022/2 | 2.22 | 2021/2 | 1.78 | 2020/2 | 1.64 |
| 2024/3 | 1.8 | 2023/3 | 1.93 | 2022/3 | 2.49 | 2021/3 | 2.39 | 2020/3 | 1.92 |
| N/A | N/A | 2023/4 | 1.72 | 2022/4 | 2.56 | 2021/4 | 2.3 | 2020/4 | 2.01 |
| N/A | N/A | 2023/5 | 1.8 | 2022/5 | 5.16 | 2021/5 | 2.28 | 2020/5 | 1.77 |
| N/A | N/A | 2023/6 | 1.76 | 2022/6 | 5.08 | 2021/6 | 2.42 | 2020/6 | 1.71 |
| N/A | N/A | 2023/7 | 1.77 | 2022/7 | 3.29 | 2021/7 | 2.74 | 2020/7 | 1.8 |
| N/A | N/A | 2023/8 | 1.85 | 2022/8 | 2.17 | 2021/8 | 2.63 | 2020/8 | 1.62 |
| N/A | N/A | 2023/9 | 1.97 | 2022/9 | 1.94 | 2021/9 | 2.8 | 2020/9 | 1.75 |
| N/A | N/A | 2023/10 | 1.88 | 2022/10 | 1.98 | 2021/10 | 2.65 | 2020/10 | 1.77 |
| N/A | N/A | 2023/11 | 1.8 | 2022/11 | 2.1 | 2021/11 | 2.62 | 2020/11 | 1.88 |
| N/A | N/A | 2023/12 | 1.64 | 2022/12 | 2.12 | 2021/12 | 2.46 | 2020/12 | 1.99 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 23Q4 (20) | 0.1 | -23.08 | -37.5 |
| 23Q3 (19) | 0.13 | 18.18 | -7.14 |
| 23Q2 (18) | 0.11 | -21.43 | 57.14 |
| 23Q1 (17) | 0.14 | -12.5 | 75.0 |
| 22Q4 (16) | 0.16 | 14.29 | 33.33 |
| 22Q3 (15) | 0.14 | 100.0 | 75.0 |
| 22Q2 (14) | 0.07 | -12.5 | -50.0 |
| 22Q1 (13) | 0.08 | -33.33 | 60.0 |
| 21Q4 (12) | 0.12 | 50.0 | 71.43 |
| 21Q3 (11) | 0.08 | -42.86 | 0.0 |
| 21Q2 (10) | 0.14 | 180.0 | 133.33 |
| 21Q1 (9) | 0.05 | -28.57 | 0.0 |
| 20Q4 (8) | 0.07 | -12.5 | 0.0 |
| 20Q3 (7) | 0.08 | 33.33 | -11.11 |
| 20Q2 (6) | 0.06 | 20.0 | -25.0 |
| 20Q1 (5) | 0.05 | -28.57 | -54.55 |
| 19Q4 (4) | 0.07 | -22.22 | 0.0 |
| 19Q3 (3) | 0.09 | 12.5 | 0.0 |
| 19Q2 (2) | 0.08 | -27.27 | 0.0 |
| 19Q1 (1) | 0.11 | 0.0 | 0.0 |
